Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (111-120 of 271) with videos related to

Pageof 28
Sort By:
JCI Insight|October 26, 2016
The head and neck cancer immune landscape and its immunotherapeutic implicationsRajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard, et al.
Plos Medicine|May 30, 2008
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosisTimothy A Chan, Sabine Glockner, Joo Mi Yi, et al.
BMC Cancer|April 14, 2018
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapyKim A Brogden, Deepak Parashar, Andrea R Hallier, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2014
Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgeryT Jonathan Yang, Jung Hun Oh, Michael R Folkert, et al.
Journal for Immunotherapy of Cancer|May 30, 2019
Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinomaPooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo, et al.
Science Translational Medicine|September 15, 2021
Ectopic activation of the miR-200c-EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapyMinggang Zhang, Zeguo Zhao, Yuri Pritykin, et al.
Journal for Immunotherapy of Cancer|October 24, 2019
Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinomaPooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2017
Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic MarkersErik S Knudsen, Paris Vail, Uthra Balaji, et al.
Molecular Cancer|February 7, 2012
Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogeneMaria Meehan, Laavanya Parthasarathi, Niamh Moran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2012
IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic gliomaDaniel Gorovets, Kasthuri Kannan, Ronglai Shen, et al.
Pageof 28

Showing results (111-120 of 271) with videos related to

Sort By:
Pageof 28
JCI Insight|October 26, 2016
The head and neck cancer immune landscape and its immunotherapeutic implicationsRajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard, et al.
Plos Medicine|May 30, 2008
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosisTimothy A Chan, Sabine Glockner, Joo Mi Yi, et al.
BMC Cancer|April 14, 2018
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapyKim A Brogden, Deepak Parashar, Andrea R Hallier, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2014
Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgeryT Jonathan Yang, Jung Hun Oh, Michael R Folkert, et al.
Journal for Immunotherapy of Cancer|May 30, 2019
Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinomaPooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo, et al.
Science Translational Medicine|September 15, 2021
Ectopic activation of the miR-200c-EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapyMinggang Zhang, Zeguo Zhao, Yuri Pritykin, et al.
Journal for Immunotherapy of Cancer|October 24, 2019
Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinomaPooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2017
Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic MarkersErik S Knudsen, Paris Vail, Uthra Balaji, et al.
Molecular Cancer|February 7, 2012
Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogeneMaria Meehan, Laavanya Parthasarathi, Niamh Moran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2012
IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic gliomaDaniel Gorovets, Kasthuri Kannan, Ronglai Shen, et al.
Pageof 28